Advertisement
The Body: The Complete HIV/AIDS Resource Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
   
Ask the Experts About

Strategies for Treatment-Experienced HIVersStrategies for Treatment-Experienced HIVers
           
Rollover images to visit our other forums!
  
  • Email Email
  • Glossary Glossary


CD4++ count 350
Jun 30, 2008

Aside from having no other problems, with the level of 350 I was recommended to start therapy. Is there no other way?

Response from Dr. McGowan

Current US and European Guidelines suggest that initiating anti-HIV treatment should be recommended when the CD4 count reaches 350 or below. These recommendations balance the risk of developing disease or complications from having unsuppressed HIV with the risks of long-term adherence. The pendulum has been shifting back in favor of earlier treatment initiation since we have more and safer drugs than a few years ago. Every person will be different, of course, but this seems to be the safest approach to treatment. CD4 counts will vary over time, decisions on treatment can be based on the trend of the counts. If your counts have been declining and have reached 350 it would not be prudent to wait too long to start.

Best,

Joe


Previous
CD4 of 44 can climb to???
Next
Hesitant & Scared to Start My Meds

  
  • Email Email
  • Glossary Glossary


 
 
Advertisement




Q&A TERMS OF USE

This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint

Advertisement